Showing 341-350 of 7166 results for "".
DERM2024: Dr. Friedman on Atopic Dermatitis Diagnosis
https://practicaldermatology.com/conferences/derm2024/derm2024-dr-friedman-atopic-dermatitis-diagnosis/26731/Practical Dermatology Editorial Board member Adam Friedman, MD, FAAD, talks about his presentation “When It’s Not Eczema?” presented at The Dermatology Education Foundation’s DEF Essential Resource Meeting 2024 (DERM2024) NP/PA CME Conference.What are Dermatologists’ Obstacles to Buy and Bill?
https://practicaldermatology.com/conferences/maui-derm-2024/what-are-dermatologists-obstacles-to-buy-and-bill/20241/Challenges with fee schedules have prompted many dermatologists to consider the buy and bill model. In a conversation between Practical Dermatology’s Chief Medical Editor Neal Bhatia, MD and Mark Kaufmann, MD, associate clinical professor at Mount Sinai, the doctors discuss some of the opportunitiesRedefining the Discourse: Psoriasis in Diverse Skin Tones
https://practicaldermatology.com/topics/psoriasis/redefining-the-discourse-psoriasis-in-diverse-skin-tones/23856/A lack of representation for underserved ethno-racial groups in clinical data and research is an underlying factor contributing to physicians’ challenges with effectively diagnosing and treating psoriasis in patients with diverse skin tones.DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyBurnout; Qwo Campaign; Differin, Cetaphil Programs; DermTech Data: DermWireTV
https://practicaldermatology.com/topics/skin-cancer-photoprotection/burnout-qwo-campaign-differin-cetaphil-programs-dermtech-data-dermwiretv/20063/The Dr. Lorna Breen Health Care Provider Protection Act is headed to the president, as the latest Medscape Physician Burnout and Depression Report shows more than half of physicians experiencing burnout say it has a strong or severe impact on their life. Differin marks Retinoid Awareness Week. CetapDermWireTV Extra: Lubriderm Launches Skin Scholarship with the NHHF
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-extra-lubriderm-launches-skin-scholarship-with-the-nhhf/20060/Suzanne Goldstein, Senior Director of Marketing for Lubriderm, explains the Skin Scholarship sponsored by Lubriderm and created in partnership with the National Hispanic Health Foundation (NHHF). This scholarship program aims to increase representation and accessibility within the field.Exploring High-Dose Neurotoxin Injections
https://practicaldermatology.com/conferences/maui-derm-2022/exploring-high-dose-neurotoxin-injections/20055/Michael H. Gold, MD shares his thoughts on the potential benefits of high-dose neurotoxin injections for some patients. He discusses his experience and the kind of results he's been able to achieve.Winning Combinations in Cosmetic Dermatology
https://practicaldermatology.com/conferences/maui-derm-2022/winning-combinations-in-cosmetic-dermatology/20280/When it comes to ensuring the best results possible for aesthetic treatments, Suneel Chilukuri, MD says combinations are key. He discusses his approach for patients using neurotoxins, fillers, and devices.DermWireTV: A Review of 2021
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-a-review-of-2021/20039/This special edition of DermWireTV reviews some of the trends that shaped the dermatology space in 2021. The availability of vaccinations against SARS-CoV-2 brought concerns about potential cutaneous reactions. Physicians in 2021 saw a decrease in salary, as the physician employment trend continuedDilution Evolution
https://practicaldermatology.com/conferences/asds-2021/dilution-evolution/20025/Offering a global perspective on aesthetics, Hassan Galadari, MD discusses the use of hyperdilute calcium hydroxyapatite in the lower face, neck, and decolette. He describes the potential for this treatment to come to the US.